Cadrenal Therapeutics, Inc. Common Stock

General ticker "CVKD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $20.8M (TTM average)

Cadrenal Therapeutics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -22.5%.

Estimated limits based on current volatility of 5.1%: low 4.91$, high 5.43$

Factors to consider:

  • Total employees count: 3 as of 2022
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.92$, 9.93$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.80$, 6.26$]

Financial Metrics affecting the CVKD estimates:

  • Negative: with PPE of -1.1 at the end of fiscal year the price was high
  • Negative: Operating cash flow per share per price, % of -87.43 <= 0.02
  • Negative: negative Operating income
  • Negative: negative Net income
  • Positive: 42.58 < Shareholder equity ratio, % of 63.30 <= 64.15
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of -0.04 > -0.63
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term CVKD quotes

Long-term CVKD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $7.63MM $10.96MM $13.46MM
Operating Income $-7.63MM $-10.96MM $-13.46MM
Non-Operating Income $-0.72MM $0.31MM $0.22MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $4.08MM $4.21MM $4.10MM
Income(Loss) $-8.36MM $-10.65MM $-13.24MM
Profit(Loss)* $-8.36MM $-10.65MM $-13.24MM
Stockholders Equity $7.69MM $7.44MM $2.74MM
Assets $8.52MM $10.12MM $4.33MM
Operating Cash Flow $-3.53MM $-7.36MM $-12.60MM
Capital expenditure $0.00MM $0.01MM $0.01MM
Investing Cash Flow $-0.00MM $-0.01MM $-0.01MM
Financing Cash Flow $11.90MM $8.98MM $6.60MM
Earnings Per Share** $-9.63 $-8.73 $-6.64

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.